JP2023538449A5 - - Google Patents
Info
- Publication number
- JP2023538449A5 JP2023538449A5 JP2023513169A JP2023513169A JP2023538449A5 JP 2023538449 A5 JP2023538449 A5 JP 2023538449A5 JP 2023513169 A JP2023513169 A JP 2023513169A JP 2023513169 A JP2023513169 A JP 2023513169A JP 2023538449 A5 JP2023538449 A5 JP 2023538449A5
- Authority
- JP
- Japan
- Prior art keywords
- mol
- group
- substituted
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013221.3 | 2020-08-24 | ||
| GBGB2013221.3A GB202013221D0 (en) | 2020-08-24 | 2020-08-24 | Viral inhibitors |
| GB2019097.1 | 2020-12-03 | ||
| GBGB2019097.1A GB202019097D0 (en) | 2020-12-03 | 2020-12-03 | Viral inhibitors |
| GBGB2105404.4A GB202105404D0 (en) | 2021-04-15 | 2021-04-15 | Viral inhibitors |
| GB2105404.4 | 2021-04-15 | ||
| PCT/GB2021/052199 WO2022043678A1 (en) | 2020-08-24 | 2021-08-24 | Viral inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538449A JP2023538449A (ja) | 2023-09-07 |
| JP2023538449A5 true JP2023538449A5 (https=) | 2024-08-14 |
Family
ID=77655566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513169A Pending JP2023538449A (ja) | 2020-08-24 | 2021-08-24 | ウイルス阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230330132A1 (https=) |
| EP (1) | EP4199937A1 (https=) |
| JP (1) | JP2023538449A (https=) |
| CN (1) | CN116367843A (https=) |
| AU (1) | AU2021333748A1 (https=) |
| CA (1) | CA3192515A1 (https=) |
| MX (1) | MX2023002109A (https=) |
| WO (1) | WO2022043678A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3194032A1 (en) * | 2020-09-04 | 2022-03-10 | The University Of Chicago | Materials and methods of treating viral infection with amphiphilic block copolymers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0221941D0 (en) * | 2002-09-20 | 2002-10-30 | Univ Strathclyde | Polysoaps |
| CN100577179C (zh) * | 2003-05-08 | 2010-01-06 | 天津帝士力投资控股集团有限公司 | 甲壳素和壳聚糖及其衍生物在制备抗病毒剂中的应用 |
| GB0320638D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| GB0615834D0 (en) | 2006-08-09 | 2006-09-20 | Univ Glasgow | Polymeric micellar clusters and their uses in formulating drugs |
| JP6028968B2 (ja) * | 2012-02-24 | 2016-11-24 | 学校法人順天堂 | 抗インフルエンザウイルス剤 |
| PL225045B1 (pl) * | 2012-05-18 | 2017-02-28 | Univ Jagiellonski | Zastosowanie polimeru chitozanowego do wytwarzania leków do leczenia i profilaktyki infekcji wywołanych przez koronawirusy |
| GB201319437D0 (en) * | 2013-11-04 | 2013-12-18 | Nanomerics Ltd | Delivery of drugs |
| WO2020039463A1 (en) * | 2018-08-23 | 2020-02-27 | Haskoli Islands | Chitosan derivatives and methods for preparing the same |
-
2021
- 2021-08-24 WO PCT/GB2021/052199 patent/WO2022043678A1/en not_active Ceased
- 2021-08-24 CA CA3192515A patent/CA3192515A1/en active Pending
- 2021-08-24 JP JP2023513169A patent/JP2023538449A/ja active Pending
- 2021-08-24 US US18/023,195 patent/US20230330132A1/en active Pending
- 2021-08-24 MX MX2023002109A patent/MX2023002109A/es unknown
- 2021-08-24 EP EP21766198.2A patent/EP4199937A1/en not_active Withdrawn
- 2021-08-24 AU AU2021333748A patent/AU2021333748A1/en not_active Abandoned
- 2021-08-24 CN CN202180066866.0A patent/CN116367843A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0735859B1 (en) | A pharmaceutical composition for the intranasal administration of hydroxocobalamin | |
| JP2018188440A5 (https=) | ||
| HU197840B (en) | Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin | |
| RU2001108569A (ru) | Стабилизированная фармацевтическая композиция в лиофилизированной форме | |
| RU2014139169A (ru) | Парентеральные составы для введения макролидных антибиотиков | |
| JP2022527556A5 (https=) | ||
| JP2002525329A5 (https=) | ||
| JP2022513089A5 (https=) | ||
| JP2024507788A5 (https=) | ||
| RU2009123536A (ru) | Стабильные парентеральные составы, включающие ингибиторы pcb на основе бензодиазепина | |
| JP2021534160A5 (https=) | ||
| JP2023538449A5 (https=) | ||
| RU2002128917A (ru) | Полиаминные аналоги в качестве цитотоксических агентов | |
| JP2023546565A5 (https=) | ||
| JP2025511227A5 (https=) | ||
| JP2025118775A5 (https=) | ||
| JP2006524227A5 (https=) | ||
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| RU99122032A (ru) | Производные доластатина-15 в комбинации с таксанами | |
| JP2008189677A (ja) | 洗浄剤 | |
| JP2023520703A5 (https=) | ||
| KR910018341A (ko) | 신규 α-만노시다제 및 푸코시다제 억제제 | |
| JP2025501169A5 (https=) | ||
| JP2016539100A5 (https=) | ||
| KR20070012522A (ko) | 면역조절제 화합물로의 호흡기 바이러스 감염의 치료 및예방 |